EVER · EverQuote, Inc. · Stock research

Current Thesis

The binary flagged in the prior read resolved on 2026-08-03, and it resolved against the plateau case. Q2'26 revenue printed $195.1M, +25% YoY, above the $190.4M consensus and above the Q1'26 figure of $190.9M that had capped three consecutive quarters near $190M. Variable Marketing Dollars came in at $56.9M against $45.5M a year earlier; adjusted EBITDA hit a record $30.1M versus $22.0M in Q2'25, with margin at 15.4% against 14.0%. Diluted EPS was $0.53 against a $0.51 estimate, and GAAP net income was $19.2M. Management then guided Q3 revenue to $198.0–208.0M, a band whose midpoint sits above the $201.6M consensus.

That changes the shape of the read. Through June the case rested on the tape — a 2026-06-26 reclaim of the declining ~$20.30 200-day moving average, +6.91% to $23.20 on 2.64M shares against a ~646K average — over a revenue line that had stopped growing sequentially. The August print supplied the fundamental leg that was missing: the deceleration string of +83% → +34% → +20% → +32% → +15% turned back up to +25%, and the growth came from both verticals, auto $172.1M (+23%) and home & renters $23.0M (+35%).

What the tape has not done is confirm with a new high. The last completed daily close was $25.71 on 2026-08-07, 7.8% under the $27.87 52-week high set in December 2025, with RSI(14) at 42.2 and a 3-month return of +25.4%. The average analyst target compiled by S&P Global across eight analysts is $25.83 — effectively where the stock closed. The narrative leg an investor buys here is the second act: that the AI-solutions push into P&C carrier workflows keeps revenue compounding toward the reiterated $1B target while the ad-spend cycle stays intact. That is a slower, more provable story than the 2024–25 snapback, and it now has to be earned quarter by quarter.

Life-cycle: MATURING. The name has been publicly covered since 2026-05-06 in this series and far longer by the street; the 2026-08-03 beat and guide-up drew PT raises the following day (B. Riley to $34, Needham to $30) rather than new discovery, and price did not clear its December 2025 high on the news. Well known, still working, flow moderating.

Bullish and bearish views on EverQuote, Inc.

The model's bull view on EverQuote, Inc. (EVER), in brief: The plateau broke (2026-08-03): Q2'26 revenue $195.1M, +25% YoY, above both the $190.4M consensus and Q1'26's $190.9M — the first clean sequential step out of the ~$190M band that had held for three quarters. The bear view: Profit dollars were guided flat-to-down: the Q3 adjusted EBITDA range of $28.0–31.0M brackets the Q2 record of $30.1M with its midpoint below it, while revenue is guided up sequentially. Both cases follow in full.

Bull Case

• The plateau broke (2026-08-03): Q2'26 revenue $195.1M, +25% YoY, above both the $190.4M consensus and Q1'26's $190.9M — the first clean sequential step out of the ~$190M band that had held for three quarters.
• Record profit dollars: adjusted EBITDA $30.1M, +37% from $22.0M in Q2'25; margin 15.4% versus 14.0%. GAAP net income $19.2M, diluted EPS $0.53 against a $0.51 estimate.
• Unit economics improved, not just volume: Variable Marketing Dollars $56.9M versus $45.5M in Q2'25, landing near the top of the $55–57M guide band set in May.
• Guide-up, not a guide-down after a beat: Q3'26 revenue guided $198.0–208.0M, midpoint above the $201.6M consensus; VMD $56.0–59.0M; adjusted EBITDA $28.0–31.0M.
• Both verticals contributing (Q2'26): auto $172.1M, +23%; home & renters $23.0M, +35%. The home leg is growing faster off a small base, which is the mix management has pointed at for TAM expansion.
• Balance sheet funds the story: $192.3M cash and no debt at 2026-06-30, up from $178.5M at 2026-03-31, after repurchasing 578,000 shares for $9.1M during the quarter. CFO Joseph Sanborn reiterated the path to $1B in revenue in the 2026-08-03 release.
• Sell-side re-rated the same week: B. Riley Securities reiterated Buy and raised its target to $34, Needham maintained Buy and raised to $30, both on 2026-08-04.

Bear Case

• Profit dollars were guided flat-to-down: the Q3 adjusted EBITDA range of $28.0–31.0M brackets the Q2 record of $30.1M with its midpoint below it, while revenue is guided up sequentially. The VMD guide of $56.0–59.0M sits barely above the $56.9M just delivered. Incremental revenue is being bought with more marketing.
• Price did not confirm: $25.71 close on 2026-08-07 is 7.8% below the $27.87 December 2025 high. A 25% revenue beat, a record EBITDA and a guide-up did not produce a new high in the four sessions that followed.
• Valuation caught up to the street: the S&P Global consensus average target of $25.83 sits on the close. The upside case now depends on the $30–34 outliers being right rather than on a gap to the average.
• Coverage of the reaction was split: Investing.com's 2026-08-03 earnings-call transcript ran under a "shares slide" headline; a StockStory note dated 2026-08-07 described a 9.4% intraday advance attributed to the same results. Choppy two-way tape around a beat is weak evidence of an expanding bid.

• Repurchase pace halved: $9.1M of buybacks in Q2 against $19.9M in Q1'26, despite a larger cash balance.
• Single-cycle exposure: $172.1M of $195.1M Q2 revenue came from auto. The revenue line is carrier and agent customer-acquisition budgets, which compress when P&C underwriting margins compress.

Setup & Price Structure

• Last completed daily close $25.71 (2026-08-07). 52-week high $27.87, set in December 2025; distance -7.8%. Three-month return +25.4%. RSI(14) 42.2 — a mid-range momentum reading, well short of overbought, which is unusual for a stock this close to a 52-week high and describes a tape that has cooled since the print.
• The 2026-06-26 reclaim of the ~$20.30 200-DMA (+6.91% to $23.20 on 2.64M shares, roughly 4x the ~646K average) has held for six weeks and now sits far under the market.
• The $23.82 June swing high, overhead resistance in the prior read, was cleared on the post-print advance. It is the first structural shelf beneath current price and the level that defines whether the reaction to 2026-08-03 survives.
• Overhead: the $27.87 December 2025 high is the level that would mark the narrative re-accelerating rather than maturing. It has not been tested since the print.
• Crowding observables, stated as observables: two target raises inside one session on 2026-08-04; an average consensus target ($25.83) sitting on the close; three named officers selling in the first eight days of July at $24.15–$24.63; a buyback that stepped down QoQ; historically thin average daily volume in the ~328K–646K range, which makes both directions gappy.

Catalyst Calendar (next 30 days)

• 2026-08-08 to 2026-09-07 — no confirmed company-dated catalyst. The Q2 release, guidance and Form 10-Q all landed on/around 2026-08-03. The window is empty of scheduled company events, so price action in it is flow and read-through rather than news.
• ~2026-08-19 (est.) and ~mid-September (est.) — Progressive monthly results releases. PGR reports monthly; its advertising and policy-acquisition commentary is the closest leading read on the carrier budgets that fund EverQuote's revenue. Exact dates not confirmed.
• ~2026-11-02 (est.) — Q3 FY2026 print. The next company binary: whether revenue lands inside $198.0–208.0M and whether adjusted EBITDA clears the $30.1M Q2 record or settles into the $28.0–31.0M guided range.

What Would Change Our Mind

The structure that has to fail first is the shelf the August print created. Giving back the entire reaction to 2026-08-03 would say the market rejected a 25% revenue quarter, a record EBITDA and a guide-up — and at that point the fundamental leg has no tape behind it. Concretely: a weekly close below $23.82 puts price back under the June swing high and negates the post-print structure. A secondary condition is the margin question — Q3 adjusted EBITDA printing at or below the $28.0M guide floor, or Q3 revenue below $198.0M, would reinstate the plateau read that the August quarter retired. On the other side, a daily close above $27.87 on expanding volume would re-date the life-cycle label from MATURING toward ACCELERATING, because it would mean new money is paying above the December 2025 high rather than rotating within the existing holder base.

Correlation Notes

• MediaAlpha (MAX) is the closest public comparable — same insurance customer-acquisition marketplace model, same carrier ad-spend cycle. Divergence between the two on a shared quarter is information about company-specific execution.
• Progressive (PGR) and Allstate (ALL) are the demand side. Their acquisition-spend disclosures lead EverQuote's revenue; a carrier signalling lower advertising is the upstream warning.
• Root (ROOT), Lemonade (LMND) and the insurtech complex trade on a related risk appetite, but their loss-ratio drivers are different — correlation is sentiment-level, not mechanical.
• Despite the AI-solutions framing in management's language, this is not an AI-infrastructure name; any correlation to semiconductor or hyperscaler tape is incidental and should not be traded as read-through.
• Theme classification has drifted across consumer-discretionary, consumer-credit and health-services labels in automated tagging. The operative driver is P&C carrier and agent acquisition budgets; anything else mis-frames the cycle the stock is exposed to.